Login / Signup
Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?
António Tralhão
Luís Ferreira Moita
Pedro Póvoa
Published in:
Critical care (London, England) (2020)
Keyphrases
</>
angiotensin ii
angiotensin converting enzyme
vascular smooth muscle cells
sars cov
human health
risk assessment